Pre-procedure knowledge of a positive multi-target stool DNA test improves neoplasia diagnosis rates among colonscopoists with lower baseline adenoma detection rates, independent of withdrawal time Derek Ebner M.D. John Kisiel Mayo Clinic Gastroenterology & Hepatology bit.ly/3QflB8i